Novartis Ag (NVSEF) Revenue Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Revenue Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 4.37%
Jun 30, 2024 1.24%
Dec 31, 2023 149.93%
Jun 30, 2023 -2.76%
Mar 31, 2023 8.85%
Dec 31, 2022 4.69%
Sep 30, 2022 4.21%
Jun 30, 2022 0.87%
Dec 31, 2021 -12.04%
Sep 30, 2021 3.86%
Jun 30, 2021 141.11%
Mar 31, 2021 1,615.73%
Dec 31, 2020 30.07%
Sep 30, 2020 27,635.87%
Jun 30, 2020 3,616.65%
Mar 31, 2020 1,639.65%
Jun 30, 2019 4,054.95%
Mar 31, 2019 1,851.63%
Dec 31, 2018 1,183.33%
Jun 30, 2018 3,070.08%